Dr. Sandeep Gupta, MD

Psychiatry Wilmington, DE Male
NPI: 1972577005
Total Payments
$15,589
2024 Payments
$10,207
Companies
33
Transactions
245
Medicare Patients
2,469
Medicare Billing
$515,296

Payment Breakdown by Category

Research$11,652 (74.7%)
Food & Beverage$3,833 (24.6%)
Education$104.17 (0.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $11,652 30 74.7%
Food and Beverage $3,833 212 24.6%
Education $104.17 3 0.7%

Payments by Type

Research
$11,652
30 transactions
General
$3,937
215 transactions

Top Paying Companies

Company Total Records Latest Year
Teva Pharmaceuticals USA, Inc. $11,800 39 $0 (2024)
Otsuka America Pharmaceutical, Inc. $443.82 27 $0 (2024)
ABBVIE INC. $390.88 25 $0 (2023)
Janssen Pharmaceuticals, Inc $337.21 14 $0 (2024)
Sunovion Pharmaceuticals Inc. $293.83 19 $0 (2022)
Neurocrine Biosciences, Inc. $286.81 11 $0 (2024)
Bausch Health US, LLC $258.30 14 $0 (2024)
ITI, Inc. $180.55 8 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $173.84 11 $0 (2022)
Alkermes, Inc. $159.98 8 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $10,207 52 Teva Pharmaceuticals USA, Inc. ($9,669)
2023 $2,534 29 Teva Pharmaceuticals USA, Inc. ($2,025)
2022 $707.90 36 ABBVIE INC. ($141.33)
2021 $652.20 37 AbbVie Inc. ($171.49)
2020 $319.91 16 Otsuka America Pharmaceutical, Inc. ($72.00)
2019 $555.02 32 Janssen Pharmaceuticals, Inc ($125.74)
2018 $413.05 28 Bausch Health US, LLC ($66.38)
2017 $200.15 15 Valeant Pharmaceuticals North America LLC ($43.66)

All Payment Transactions

245 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
12/11/2024 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) — Cash or cash equivalent $362.00 Research
Study: TV50717-CNS-40223 • Category: Central Nervous System
12/11/2024 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) — Cash or cash equivalent $227.00 Research
Study: TV50717-CNS-40223 • Category: Central Nervous System
12/10/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $17.93 General
Category: PSYCHIATRY
12/03/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $96.23 General
Category: Neuropsychiatry
12/03/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $25.72 General
Category: PSYCHIATRY
11/13/2024 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) — Cash or cash equivalent $362.00 Research
Study: TV50717-CNS-40223 • Category: Central Nervous System
11/13/2024 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) — Cash or cash equivalent $227.00 Research
Study: TV50717-CNS-40223 • Category: Central Nervous System
11/06/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $15.53 General
Category: CNS
10/25/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $26.01 General
Category: Psychiatry/Psychology
10/16/2024 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) — Cash or cash equivalent $362.00 Research
Study: TV50717-CNS-40223 • Category: Central Nervous System
10/16/2024 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) — Cash or cash equivalent $362.00 Research
Study: TV50717-CNS-40223 • Category: Central Nervous System
10/16/2024 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) — Cash or cash equivalent $227.00 Research
Study: TV50717-CNS-40223 • Category: Central Nervous System
10/11/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $21.78 General
Category: PSYCHIATRY
10/11/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $14.32 General
Category: PSYCHIATRY
10/09/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $5.13 General
Category: PSYCHIATRY
10/04/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Education In-kind items and services $27.27 General
Category: Psychiatry/Psychology
09/18/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $23.86 General
Category: PSYCHIATRY
09/04/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $18.81 General
Category: PSYCHIATRY
08/29/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA Food and Beverage In-kind items and services $25.52 General
Category: PSYCHIATRY
08/27/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $16.17 General
Category: PSYCHIATRY
08/21/2024 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) — Cash or cash equivalent $227.00 Research
Study: TV50717-CNS-40223 • Category: Central Nervous System
08/21/2024 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) — Cash or cash equivalent $227.00 Research
Study: TV50717-CNS-40223 • Category: Central Nervous System
08/21/2024 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) — Cash or cash equivalent $227.00 Research
Study: TV50717-CNS-40223 • Category: Central Nervous System
08/21/2024 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) — Cash or cash equivalent $227.00 Research
Study: TV50717-CNS-40223 • Category: Central Nervous System
08/21/2024 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) — Cash or cash equivalent $227.00 Research
Study: TV50717-CNS-40223 • Category: Central Nervous System
123…10»

Research Studies & Clinical Trials

Study Name Company Amount Records
TV50717-CNS-40223 Teva Pharmaceuticals USA, Inc. $11,652 30

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 622 2,021 $281,465 $120,978
2022 7 637 1,396 $287,569 $100,059
2021 7 600 1,477 $356,407 $124,735
2020 8 610 1,800 $486,041 $169,525
Total Patients
2,469
Total Services
6,694
Medicare Billing
$515,296
Procedure Codes
30

All Medicare Procedures & Services

30 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 181 517 $103,400 $45,533 44.0%
90868 Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management Office 2023 11 255 $89,250 $39,932 44.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 159 286 $45,760 $16,915 37.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 12 61 $15,250 $8,582 56.3%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2023 46 64 $6,400 $2,925 45.7%
96127 Assessment of emotional or behavioral problems Office 2023 182 807 $12,105 $2,749 22.7%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 14 14 $4,200 $2,260 53.8%
90792 Psychiatric diagnostic evaluation with medical services Office 2023 17 17 $5,100 $2,082 40.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 199 522 $104,400 $47,384 45.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 218 494 $79,040 $29,986 37.9%
90870 Therapy using electrical currents Facility 2022 20 102 $76,304 $8,779 11.5%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2022 73 135 $13,500 $6,606 48.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 24 30 $7,500 $4,086 54.5%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 18 18 $5,400 $2,856 52.9%
96127 Assessment of emotional or behavioral problems Office 2022 85 95 $1,425 $362.84 25.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 199 533 $106,600 $51,676 48.5%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 237 517 $82,720 $32,831 39.7%
90870 Shock treatment and monitoring Facility 2021 29 174 $123,337 $15,374 12.5%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 23 71 $17,750 $10,480 59.0%
90833 Psychotherapy performed with evaluation and management visit, 30 minutes Office 2021 68 138 $13,800 $7,550 54.7%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 29 29 $8,550 $4,850 56.7%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 15 15 $3,650 $1,974 54.1%
90868 Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), per session Office 2020 18 445 $155,750 $68,268 43.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 201 581 $116,200 $45,343 39.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 220 468 $74,880 $25,322 33.8%
12»

About Dr. Sandeep Gupta, MD

Dr. Sandeep Gupta, MD is a Psychiatry healthcare provider based in Wilmington, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972577005.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandeep Gupta, MD has received a total of $15,589 in payments from pharmaceutical and medical device companies, with $10,207 received in 2024. These payments were reported across 245 transactions from 33 companies. The most common payment nature is "" ($11,652).

As a Medicare-enrolled provider, Gupta has provided services to 2,469 Medicare beneficiaries, totaling 6,694 services with total Medicare billing of $515,296. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Wilmington, DE
  • Active Since 02/15/2006
  • Last Updated 04/01/2013
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1972577005

Products in Payments

  • AUSTEDO (Drug) $11,744
  • VRAYLAR (Drug) $487.93
  • REXULTI (Drug) $473.35
  • LATUDA (Drug) $293.83
  • INGREZZA (Drug) $286.81
  • CAPLYTA (Drug) $230.13
  • SPRAVATO (Drug) $208.87
  • APLENZIN (Drug) $188.40
  • TRINTELLIX (Drug) $127.30
  • LYBALVI (Drug) $101.86
  • QUVIVIQ (Drug) $95.33
  • Trintellix (Drug) $82.98
  • VYVANSE (Drug) $80.02
  • INVEGA SUSTENNA (Drug) $80.01
  • NUEDEXTA (Drug) $78.31
  • WELLBUTRIN XL (Drug) $77.87
  • Fanapt (Drug) $72.24
  • QELBREE (Drug) $66.01
  • SUNOSI (Drug) $59.20
  • JORNAY PM (Drug) $58.20

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Wilmington

Dr. Ranganathan Ram

Psychiatry — Payments: $362,123

Psychiatry $362,123

Dr. Paul Buongiorno, M.d, M.D

Psychiatry — Payments: $262,847

Psychiatry $262,847

Dr. Eric Christopher, M.d, M.D

Psychiatry — Payments: $89,218

Psychiatry $89,218

Dr. Manisha Wadhwa, M.d, M.D

Psychiatry — Payments: $71,032

Psychiatry $71,032

Rano Mathew, Md, MD

Psychiatry — Payments: $13,650

Psychiatry $13,650

Dr. Brett Gurkin, M.d, M.D

Psychiatry — Payments: $9,247

Psychiatry $9,247